CAR T-cell therapy harnesses the power of the immune system, particularly T cells, to combat cancer effectively. The process begins by extracting a patient's T cells from their blood. These cells are then genetically engineered in a laboratory to express CARs on their surface. CARs are synthetic receptors that enable T cells to recognize specific antigens present on cancer cells.
Mechanism of Action
Download latest CAR-T Market Report @ https://www.delveinsight.com/s....ample-request/chimer
Like
Comment
Share
